Pralsetinib Market Share, Size, Demand, Key Players by Forecast 2034

bir ses eklendi Health

2024-12-31 12:14:38 - Translate -

Pralsetinib Market Outlook 2034 Pralsetinib, market under the brand name Gavreto, has emerged as a promising treatment option for patients with specific types of cancer harboring RET gene alterations. This targeted therapy has demonstrated significant efficacy in treating metastatic non-small cell lung cancer (NSCLC) and advanced RET fusion-positive thyroid cancer. Unlock your exclusive...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme